Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphomaJia Ruan, Peter W. Martin, Zhengming Chen et al.|Blood|2023Cited by 47
High Rates of Remission with the Initial Treatment of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes and Biomarker Analysis of a Multi-Center Phase II StudyJia Ruan, Leandro Cerchietti, Alison J. Moskowitz et al.|Blood|2021Cited by 11